Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00413062
Status:
COMPLETED
Last Update Posted:
2022-02-09
First Post:
2006-12-18
Brief Title:
Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSPEE 292002P05722
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
A Randomized Open-Label Comparative Multi -Center Trial to Evaluate Contraceptive Efficacy Cycle Control Safety and Acceptability of a Monophasic Combined Oral Contraceptive COC Containing 25 mg Nomegestrol Acetate NOMAC and 15 mg Estradiol E2 Compared to a Monophasic COC Containing 3 mg Drospirenone DRSP and 30 µg Ethinyl Estradiol EE
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary purpose of this study is to assess contraceptive efficacy vaginal bleeding patterns cycle control general safety and acceptability of the nomegestrol acetate-estradiol NOMAC-E2 combined oral contraceptive COC in a large group of women aged 18-50 years
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 292002 | None | None | None |